2007
DOI: 10.1364/ao.46.003359
|View full text |Cite
|
Sign up to set email alerts
|

Feasibility analysis of an epidermal glucose sensor based on time-resolved fluorescence

Abstract: The goal of this paper is to present numerical simulations predicting the timeresolved autofluorescence of human skin at 577 nm exposed to a pulse of collimated light at 337 nm and pulse width of 1 ns. Moreover, it investigates the feasibility of using an Finally, the glucose concentrations within the skin were recovered within 13.5 % of their actual values, indicating a possibility of measuring glucose concentrations using a time-resolved fluorescence sensor.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 45 publications
(71 reference statements)
0
8
0
Order By: Relevance
“…For example, development of methods to report blood glucose levels noninvasively has been the Holy Grail of diabetes-related studies. A recent report demonstrated the feasibility of using fluorescence lifetime of an implanted sensor for continuous measurement of glucose concentration in blood 502. Without doubt, noninvasive lifetime-based devices and methods will be developed in future.…”
Section: Fluorescence Lifetime Imaging Applicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, development of methods to report blood glucose levels noninvasively has been the Holy Grail of diabetes-related studies. A recent report demonstrated the feasibility of using fluorescence lifetime of an implanted sensor for continuous measurement of glucose concentration in blood 502. Without doubt, noninvasive lifetime-based devices and methods will be developed in future.…”
Section: Fluorescence Lifetime Imaging Applicationsmentioning
confidence: 99%
“…A recent report demonstrated the feasibility of using fluorescence lifetime of an implanted sensor for continuous measurement of glucose concentration in blood. 502 Without doubt, noninvasive lifetimebased devices and methods will be developed in future.…”
Section: Diabetes and Kidney Pathologiesmentioning
confidence: 99%
“…Furthermore, the reports of blood-borne infection have been noted with these invasive glucose sensors. For these reasons, new techniques have been employed to develop a minorly invasive and/or noninvasive device for blood glucose monitoring, including infrared (IR) spectroscopy, [3][4][5] fluorescence spectroscopy, [6][7] Raman spectroscopy, [8][9] optical polarization rotation measurement, [10][11][12][13] photoacoustic probes, 14 and surface plasmon resonance. [15][16] However, results from these techniques need to be checked frequently against direct blood glucose measurements, that is, they cannot replace the direct measure of a blood glucose sensor.…”
Section: Introductionmentioning
confidence: 99%
“…The methods applied include infrared (IR) spectroscopy, , Raman spectroscopy, , optical coherence tomography, and measurement of tissue metabolic heat conformation; however, none are currently proven to be useful clinically . In addition, several in vivo sensing approaches have been proposed, including fluorescence spectroscopy, , surface plasmon resonance of nanoparticles, , electrical impedance measurements, and implantable/subcutaneous amperometric glucose sensors . Among these, only subcutaneous electrochemical glucose sensors are available commercially, although frequent calibration, short in vivo lifetimes, limited accuracy, and high cost have prevented their widespread use …”
mentioning
confidence: 99%